Published in Eur Radiol on September 22, 2012
Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors. Medicine (Baltimore) (2015) 0.79
Contrast-enhanced ultrasound imaging for the detection of focused ultrasound-induced blood-brain barrier opening. Theranostics (2014) 0.77
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development. Cancer Metastasis Rev (2015) 0.75
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (2009) 77.71
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res (2000) 6.42
Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation (1998) 5.93
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol (2006) 5.17
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer (2009) 2.38
Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol (2003) 2.03
Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA (2010) 1.84
Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med (2007) 1.79
Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy. Radiology (2010) 1.77
Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol (2009) 1.67
Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol (2010) 1.62
Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol (2000) 1.57
Quantitative volumetric perfusion mapping of the microvasculature using contrast ultrasound. Invest Radiol (2010) 1.54
Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol (2008) 1.37
Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging (2008) 1.30
Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res (2007) 1.25
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol (2010) 1.25
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology (2011) 1.25
Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. J Vasc Interv Radiol (2010) 1.23
Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol (2008) 1.21
Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol (2008) 1.17
Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol (2010) 1.13
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. J Hepatol (2011) 0.98
Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model. J Vasc Interv Radiol (2010) 0.96
Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol (2010) 0.96
Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results. Eur Radiol (2005) 0.93
Vascular lesions and s-thrombomodulin concentrations from auricular arteries of rabbits infused with microbubble contrast agent and exposed to pulsed ultrasound. Ultrasound Med Biol (2006) 0.92
Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. Ultrasound Med Biol (2004) 0.91
Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model. Invest Radiol (2006) 0.91
Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization. World J Gastroenterol (2004) 0.87
New treatment strategies in advanced neuroendocrine tumours. Dig Liver Dis (2011) 0.86
Retraction notice: Padhani A. PET imaging of tumour hypoxia, Cancer Imaging 2006; 6: s117-s121. Cancer Imaging (2007) 0.83
Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival. Eur Radiol (2011) 0.82
Prolonged local persistence of cisplatin-loaded gelatin microspheres and their chemoembolic anti-cancer effect in rabbits. Eur J Radiol (2008) 0.80
Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation. Ultrasound Med Biol (2012) 0.76
Unenhanced and contrast-enhanced ultrasonography during hepatic transarterial embolization and chemoembolization with drug-eluting beads. Cardiovasc Intervent Radiol (2010) 0.75
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.93
Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature (2010) 9.95
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol (2009) 4.82
Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol (2012) 3.56
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. J Clin Oncol (2009) 3.18
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging. Nat Methods (2010) 2.93
Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial. Lancet Oncol (2011) 2.26
Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. Neuroendocrinology (2004) 2.16
Reverse transfection on cell arrays for high content screening microscopy. Nat Protoc (2007) 2.09
Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics (2005) 1.85
Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy. Radiology (2010) 1.77
Visualizing biological data-now and in the future. Nat Methods (2010) 1.61
Micropilot: automation of fluorescence microscopy-based imaging for systems biology. Nat Methods (2011) 1.59
Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Blood (2008) 1.58
Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med (2010) 1.53
Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences. Hepatology (2008) 1.51
Coronary computed tomography and triple rule out CT in patients with acute chest pain and an intermediate cardiac risk profile. Part 1: impact on patient management. Eur J Radiol (2012) 1.50
Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation. Radiology (2013) 1.45
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol (2005) 1.43
Total and segmental liver volume variations: implications for liver surgery. Surgery (2004) 1.41
Technical innovation. Optimization of multidetector CT venography performed with elastic stockings on patients' lower extremities: A preliminary study of nonthrombosed veins. AJR Am J Roentgenol (2003) 1.39
Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology (2004) 1.38
Migrated foreign body liver abscess: illustrative case report, systematic review, and proposed diagnostic algorithm. Medicine (Baltimore) (2010) 1.33
Nonoperative management of traumatic splenic injuries: is there a role for proximal splenic artery embolization? AJR Am J Roentgenol (2006) 1.30
Potential exposure to hepatitis C virus through accidental blood contact in interventional radiology. J Vasc Interv Radiol (2003) 1.29
Conservative management of pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg (2004) 1.29
Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolism. Eur J Endocrinol (2014) 1.28
Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial. AJR Am J Roentgenol (2011) 1.26
Complete genome sequence of Mycoplasma suis and insights into its biology and adaption to an erythrocyte niche. PLoS One (2011) 1.19
Malignant gastroduodenal obstruction: palliation with self-expanding metallic stents. J Vasc Interv Radiol (2005) 1.19
Palliative portal vein stent placement in malignant and symptomatic extrinsic portal vein stenosis or occlusion. Cardiovasc Intervent Radiol (2008) 1.19
Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol (2010) 1.13
VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway. Neuroendocrinology (2010) 1.12
Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy? Eur J Gastroenterol Hepatol (2010) 1.10
Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors. Eur J Gastroenterol Hepatol (2013) 1.08
Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of "sign-by-sign" correlation. Eur Radiol (2002) 1.07
Portal uptake function in veno-occlusive regions evaluated by real-time fluorescent imaging using indocyanine green. J Hepatol (2013) 1.07
Life-threatening rectal bleeding with Klippel-Trenaunay syndrome controlled by angiographic embolization and rectal clips. J Pediatr Gastroenterol Nutr (2006) 1.06
Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology (2003) 1.05
Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells. J Biol Chem (2004) 1.04
Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives. Crit Rev Oncol Hematol (2009) 1.03
CT enteroclysis: technique and clinical applications. Eur Radiol (2005) 1.02
Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease. Bull Cancer (2006) 1.02
Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol (2007) 1.02
EML3 is a nuclear microtubule-binding protein required for the correct alignment of chromosomes in metaphase. J Cell Sci (2008) 1.01
Echinococcal cyst. Radiographics (2004) 1.01
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. J Magn Reson Imaging (2010) 1.00
Mitotic lamin disassembly is triggered by lipid-mediated signaling. J Cell Biol (2012) 1.00
Value of CT enteroclysis in suspected small-bowel carcinoid tumors. AJR Am J Roentgenol (2010) 0.99
Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study. Invest Radiol (2014) 0.99
Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study. Invest Radiol (2012) 0.99
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study. Eur J Cancer (2009) 0.99
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. Eur J Endocrinol (2013) 0.97
Magnetic resonance cholangiography features of biliary abnormalities due to cavernous transformation of the portal vein. Clin Imaging (2006) 0.96
Enterobiliary fistula after radiofrequency ablation of liver metastases. J Vasc Interv Radiol (2003) 0.93
Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours? Eur J Cancer (2011) 0.93
Successful embolization of Rasmussen's aneurysm for severe haemoptysis. Swiss Med Wkly (2004) 0.92
Portal vein normal anatomy and variants: implication for liver surgery and portal vein embolization. Semin Intervent Radiol (2008) 0.92
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting. J Hepatol (2010) 0.91
Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol (2008) 0.91
Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol (2009) 0.91
Detection of low-contrast objects: experimental comparison of single- and multi-detector row CT with a phantom. Radiology (2002) 0.90
Percutaneous cholecystostomy for acute cholecystitis: who should really benefit from this procedure? HPB (Oxford) (2014) 0.90
Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel. World J Gastroenterol (2010) 0.89
Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients. Melanoma Res (2008) 0.89
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study. Melanoma Res (2012) 0.89
Clinical experience with retrievable Günther Tulip vena cava filters. J Endovasc Ther (2003) 0.89
Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials. Eur Radiol (2012) 0.89
Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time. Eur Radiol (2012) 0.88
Detection of suspected placental invasion by MRI: do the results depend on observer' experience? Eur J Radiol (2012) 0.88
Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol (2007) 0.88
Recurrent left colonic diverticulitis episodes: more severe than the initial diverticulitis? World J Surg (2009) 0.87
Prognostic value of perfusion defect volume at dual energy CTA in patients with pulmonary embolism: correlation with CTA obstruction scores, CT parameters of right ventricular dysfunction and adverse clinical outcome. Eur J Radiol (2012) 0.87
Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion. World J Radiol (2010) 0.87
Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factors. Am J Infect Control (2012) 0.87
New treatment strategies in advanced neuroendocrine tumours. Dig Liver Dis (2011) 0.86
Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study. Neuroendocrinology (2012) 0.86
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study. Int J Biol Markers (2011) 0.86
Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases. Eur J Endocrinol (2009) 0.86
Fusion of the planes of the liver: an anatomic entity merging the midplane and the left intersectional plane. J Am Coll Surg (2005) 0.86
Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma. FEBS Lett (2007) 0.86
Endovascular treatment of active splenic bleeding after colonoscopy: a systematic review of the literature. Cardiovasc Intervent Radiol (2012) 0.86
Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis. J Med Chem (2003) 0.85
Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results. Clin Res Hepatol Gastroenterol (2011) 0.85
Incidence of pulmonary embolism in an emergency department cohort evaluated with a simple symptom-based diagnostic algorithm. In Vivo (2013) 0.85
Influence of operator experience on performance of ultrasound-guided percutaneous liver biopsy. Eur Radiol (2004) 0.84
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-up. J Trauma (2007) 0.84
Angiogenesis and tumor progression in neuroendocrine digestive tumors. J Surg Res (2008) 0.84
Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound. Eur Radiol (2012) 0.84
Antitumor effect of everolimus in preclinical models of high-grade gastroenteropancreatic neuroendocrine carcinomas. Neuroendocrinology (2013) 0.84
Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors. Pancreas (2012) 0.83